1
|
Giussani A, Lopez MA, Romm H, Testa A, Ainsbury EA, Degteva M, Della Monaca S, Etherington G, Fattibene P, Güclu I, Jaworska A, Lloyd DC, Malátová I, McComish S, Melo D, Osko J, Rojo A, Roch-Lefevre S, Roy L, Shishkina E, Sotnik N, Tolmachev SY, Wieser A, Woda C, Youngman M. Eurados review of retrospective dosimetry techniques for internal exposures to ionising radiation and their applications. Radiat Environ Biophys 2020; 59:357-387. [PMID: 32372284 PMCID: PMC7369133 DOI: 10.1007/s00411-020-00845-y] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/08/2019] [Accepted: 04/15/2020] [Indexed: 05/17/2023]
Abstract
This work presents an overview of the applications of retrospective dosimetry techniques in case of incorporation of radionuclides. The fact that internal exposures are characterized by a spatially inhomogeneous irradiation of the body, which is potentially prolonged over large periods and variable over time, is particularly problematic for biological and electron paramagnetic resonance (EPR) dosimetry methods when compared with external exposures. The paper gives initially specific information about internal dosimetry methods, the most common cytogenetic techniques used in biological dosimetry and EPR dosimetry applied to tooth enamel. Based on real-case scenarios, dose estimates obtained from bioassay data as well as with biological and/or EPR dosimetry are compared and critically discussed. In most of the scenarios presented, concomitant external exposures were responsible for the greater portion of the received dose. As no assay is available which can discriminate between radiation of different types and different LETs on the basis of the type of damage induced, it is not possible to infer from these studies specific conclusions valid for incorporated radionuclides alone. The biological dosimetry assays and EPR techniques proved to be most applicable in cases when the radionuclides are almost homogeneously distributed in the body. No compelling evidence was obtained in other cases of extremely inhomogeneous distribution. Retrospective dosimetry needs to be optimized and further developed in order to be able to deal with real exposure cases, where a mixture of both external and internal exposures will be encountered most of the times.
Collapse
Affiliation(s)
- A Giussani
- BfS-Bundesamt für Strahlenschutz, Ingolstädter Landstr. 1, 85764, Oberschleißheim, Germany.
| | - M A Lopez
- CIEMAT - Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Av.da Complutense 40, 28040, Madrid, Spain
| | - H Romm
- BfS-Bundesamt für Strahlenschutz, Ingolstädter Landstr. 1, 85764, Oberschleißheim, Germany
| | - A Testa
- ENEA Casaccia Research Center, Via Anguillarese 301, Santa Maria di Galeria, 00123, Rome, Italy
| | - E A Ainsbury
- Public Health England - Centre for Radiation, Chemical and Environmental Hazards, Chilton, Didcot, OX11 0RQ, Oxon, UK
| | - M Degteva
- Urals Research Center for Radiation Medicine (URCRM), Vorovskt str. 68A, Chelyabinsk, 454141, Russia
| | - S Della Monaca
- Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy
| | - G Etherington
- Public Health England - Centre for Radiation, Chemical and Environmental Hazards, Chilton, Didcot, OX11 0RQ, Oxon, UK
| | - P Fattibene
- Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy
| | - I Güclu
- Cekmece Nuclear Research and Training Center Radiobiology Unit Yarımburgaz, Turkish Atomic Energy Authority, Istanbul, Turkey
| | - A Jaworska
- DSA-Norwegian Radiation and Nuclear Safety Authority, Skøyen, P. O. Box 329, 0213, Oslo, Norway
| | - D C Lloyd
- Public Health England - Centre for Radiation, Chemical and Environmental Hazards, Chilton, Didcot, OX11 0RQ, Oxon, UK
| | - I Malátová
- SURO-National Radiation Protection Institute, Bartoskova 28, 14000, Prague, Czech Republic
| | - S McComish
- US Transuranium and Uranium Registries, Washington State University, Richland, WA, USA
| | - D Melo
- Melohill Technology, 1 Research Court, Rockville, MD, 20850, USA
| | - J Osko
- National Centre for Nuclear Research, A. Soltana 7, 05400, Otwock, Poland
| | - A Rojo
- ARN-Nuclear Regulatory Authority of Argentina, Av. del Libertador 8250, Buenos Aires, Argentina
| | - S Roch-Lefevre
- Institut de Radioprotection et de Sûreté Nucléaire, IRSN, Pôle Santé et Environnement, Direction de la Santé, Fontenay-aux-Roses, France
| | - L Roy
- Institut de Radioprotection et de Sûreté Nucléaire, IRSN, Pôle Santé et Environnement, Direction de la Santé, Fontenay-aux-Roses, France
| | - E Shishkina
- Urals Research Center for Radiation Medicine (URCRM), Vorovskt str. 68A, Chelyabinsk, 454141, Russia
- Chelyabinsk State University (ChelSU), 129, Bratiev Kashirinih Street, Chelyabinsk, 454001, Russia
| | - N Sotnik
- Southern Urals Biophysics Institute (SUBI), Ozyorsk, Chelyabinsk Region, 456780, Russia
| | - S Y Tolmachev
- US Transuranium and Uranium Registries, Washington State University, Richland, WA, USA
| | - A Wieser
- Institute of Radiation Medicine, Helmholtz Zentrum München, Ingolstädter Landstr. 1, 85764, Neuherberg, Germany
| | - C Woda
- Institute of Radiation Medicine, Helmholtz Zentrum München, Ingolstädter Landstr. 1, 85764, Neuherberg, Germany
| | - M Youngman
- Public Health England - Centre for Radiation, Chemical and Environmental Hazards, Chilton, Didcot, OX11 0RQ, Oxon, UK
| |
Collapse
|
2
|
Kulka U, Ainsbury L, Atkinson M, Barnard S, Smith R, Barquinero JF, Barrios L, Bassinet C, Beinke C, Cucu A, Darroudi F, Fattibene P, Bortolin E, Monaca SD, Gil O, Gregoire E, Hadjidekova V, Haghdoost S, Hatzi V, Hempel W, Herranz R, Jaworska A, Lindholm C, Lumniczky K, M'kacher R, Mörtl S, Montoro A, Moquet J, Moreno M, Noditi M, Ogbazghi A, Oestreicher U, Palitti F, Pantelias G, Popescu I, Prieto MJ, Roch-Lefevre S, Roessler U, Romm H, Rothkamm K, Sabatier L, Sebastià N, Sommer S, Terzoudi G, Testa A, Thierens H, Trompier F, Turai I, Vandevoorde C, Vaz P, Voisin P, Vral A, Ugletveit F, Wieser A, Woda C, Wojcik A. Realising the European network of biodosimetry: RENEB-status quo. Radiat Prot Dosimetry 2015; 164:42-5. [PMID: 25205835 PMCID: PMC4401036 DOI: 10.1093/rpd/ncu266] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/20/2023]
Abstract
Creating a sustainable network in biological and retrospective dosimetry that involves a large number of experienced laboratories throughout the European Union (EU) will significantly improve the accident and emergency response capabilities in case of a large-scale radiological emergency. A well-organised cooperative action involving EU laboratories will offer the best chance for fast and trustworthy dose assessments that are urgently needed in an emergency situation. To this end, the EC supports the establishment of a European network in biological dosimetry (RENEB). The RENEB project started in January 2012 involving cooperation of 23 organisations from 16 European countries. The purpose of RENEB is to increase the biodosimetry capacities in case of large-scale radiological emergency scenarios. The progress of the project since its inception is presented, comprising the consolidation process of the network with its operational platform, intercomparison exercises, training activities, proceedings in quality assurance and horizon scanning for new methods and partners. Additionally, the benefit of the network for the radiation research community as a whole is addressed.
Collapse
Affiliation(s)
- U Kulka
- Bundesamt für Strahlenschutz, Salzgitter, Germany
| | | | - M Atkinson
- Helmholtz Centre Munich, Neuherberg, Germany
| | | | - R Smith
- Public Health England, Chilton, UK
| | - J F Barquinero
- Universitat Autonoma de Barcelona, Cerdanyola del Valles, Spain
| | - L Barrios
- Universitat Autonoma de Barcelona, Cerdanyola del Valles, Spain
| | - C Bassinet
- Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France
| | - C Beinke
- Bundeswehr Institut für Radiobiologie/Universität Ulm, Ulm, Germany
| | - A Cucu
- National Institute of Public Health Romania, Bucharest, Romania
| | - F Darroudi
- Leiden University Medical Center, Leiden, The Netherlands
| | | | - E Bortolin
- Istituto Superiore di Sanità, Rome, Italy
| | | | - O Gil
- Instituto Superior Técnico, Universidade de Lisboa, Bobadela LRS, Portugal
| | - E Gregoire
- Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France
| | - V Hadjidekova
- National Centre of Radiobiology and Radiation Protection, Sofia, Bulgaria
| | | | - V Hatzi
- National Centre for Scientific Research Demokritos, Athens, Greece
| | - W Hempel
- Commissariat à l'Énergie Atomique, Fontenay-aux-Roses, France
| | - R Herranz
- Servicio Madrileño de Salud, Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | - A Jaworska
- Norwegian Radiation Protection Authority, Osteraas, Norway
| | - C Lindholm
- Radiation and Nuclear Safety Authority, Research and Environmental Surveillance, Helsinki, Finland
| | - K Lumniczky
- National Research Institute for Radiobiology and Radiohygiene, Budapest, Hungary
| | - R M'kacher
- Commissariat à l'Énergie Atomique, Fontenay-aux-Roses, France
| | - S Mörtl
- Helmholtz Centre Munich, Neuherberg, Germany
| | - A Montoro
- Fundación para la Investigation del Hospital Universitario la Fe de la Comunidad Valenciana, Valencia, Spain
| | - J Moquet
- Public Health England, Chilton, UK
| | - M Moreno
- Servicio Madrileño de Salud, Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | - M Noditi
- National Institute of Public Health Romania, Bucharest, Romania
| | - A Ogbazghi
- Commissariat à l'Énergie Atomique, Fontenay-aux-Roses, France
| | | | - F Palitti
- University of Tuscia, Viterbo, Italy
| | - G Pantelias
- National Centre for Scientific Research Demokritos, Athens, Greece
| | - I Popescu
- National Institute of Public Health Romania, Bucharest, Romania
| | - M J Prieto
- Servicio Madrileño de Salud, Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | - S Roch-Lefevre
- Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France
| | - U Roessler
- Bundesamt für Strahlenschutz, Salzgitter, Germany
| | - H Romm
- Bundesamt für Strahlenschutz, Salzgitter, Germany
| | | | - L Sabatier
- Commissariat à l'Énergie Atomique, Fontenay-aux-Roses, France
| | - N Sebastià
- Fundación para la Investigation del Hospital Universitario la Fe de la Comunidad Valenciana, Valencia, Spain
| | - S Sommer
- Instytut Chemii i Techniki Jadrowej, Warsaw, Poland
| | - G Terzoudi
- National Centre for Scientific Research Demokritos, Athens, Greece
| | - A Testa
- Agenzia Nazionale per le Nuove Tecnologie, L'Energia e lo Sviluppo Economico Sostenibile, Rome, Italy
| | - H Thierens
- Faculty of Medicine and Health Sciences, Universiteit Gent, Gent, Belgium
| | - F Trompier
- Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France
| | - I Turai
- National Research Institute for Radiobiology and Radiohygiene, Budapest, Hungary
| | - C Vandevoorde
- Faculty of Medicine and Health Sciences, Universiteit Gent, Gent, Belgium
| | - P Vaz
- Instituto Superior Técnico, Universidade de Lisboa, Bobadela LRS, Portugal
| | - P Voisin
- Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France
| | - A Vral
- Faculty of Medicine and Health Sciences, Universiteit Gent, Gent, Belgium
| | - F Ugletveit
- Norwegian Radiation Protection Authority, Osteraas, Norway
| | - A Wieser
- Helmholtz Centre Munich, Neuherberg, Germany
| | - C Woda
- Helmholtz Centre Munich, Neuherberg, Germany
| | - A Wojcik
- Stockholm University, Stockholm, Sweden
| |
Collapse
|
3
|
Grégoire E, Hadjidekova V, Hristova R, Gruel G, Roch-Lefevre S, Voisin P, Staynova A, Deleva S, Ainsbury EA, Lloyd DC, Barquinero JF. Biological dosimetry assessments of a serious radiation accident in Bulgaria in 2011. Radiat Prot Dosimetry 2013; 155:418-422. [PMID: 23460030 DOI: 10.1093/rpd/nct032] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
In 2011, a serious radiation accident occurred in Stamboliyski, Bulgaria, in an industrial sterilisation facility using very-high-activity (60)Co sources. For the five persons accidentally exposed, biological dosimetry based on dicentric analysis was performed in Sofia and in Paris, where the patients were transferred for treatment. Before completing the chromosomal dose assessment, and for the most exposed person, a preliminary cytogenetic evaluation based on electronically transmitted metaphase images was made. The averaged acute whole-body dose estimates for the five patients ranged from 5.2 to 1.2 Gy, and good agreement was obtained between the two laboratories. The patients were also assessed by their prodromal responses and depressed blood cell counts over the first week. The cytogenetic dose estimates were in good accord with those derived from the blood counts, and both techniques indicated that, for the two most seriously exposed persons both techniques indicated that the initial prodromal reactions had suggested somewhat less severe exposure.
Collapse
Affiliation(s)
- E Grégoire
- Institut de Radioprotection et de Sûreté Nucléaire, Fontenay aux Roses, France
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
4
|
Roy L, Grégoire E, Gruel G, Roch-Lefevre S, Voisin P, Busset A, Martin C, Voisin P. Effect of lymphocytes culture variations on the mitotic index and on the dicentric yield following gamma radiation exposure. Radiat Prot Dosimetry 2012; 151:135-143. [PMID: 22234421 DOI: 10.1093/rpd/ncr460] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
Fundamentals of biological dosimetry are described in the International Atomic Energy Agency manual, but all over the world each laboratory is using its own protocol. To test the influence of protocol variations, some blood samples were exposed to 0.5 Gy of gamma radiation and mitotic index and dicentric rates were measured under different experimental conditions. The effect of seven parameters [bromodeoxyuridin (BrdU), phytohaemagglutinin and colcemid concentrations, blood and medium volumes, culture duration and incubation temperature] was tested using a Placket and Burman experimental design. The analysis reveals that the mitotic index was influenced by the concentration of BrdU, medium and blood volumes, the culture duration and the temperature. However, none of the factors has a significant impact on the yield of dicentrics. The dicentric assay is robust against reagent variations within the range tested. These results could be used by relevant laboratories as elements of their procedures robustness in any event requiring such demonstration.
Collapse
Affiliation(s)
- L Roy
- Laboratoire de Dosimétrie Biologique, Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses Cedex, France.
| | | | | | | | | | | | | | | |
Collapse
|